Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04826991 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Wells and Enteric Disease Transmission

Study acronym: WET
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Feb 28, 2027 to Mar 31, 2027v9
  2. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Dec 31, 2026 to Feb 28, 2027
    • Site details revised
    v8
  3. Primary completion date: May 31, 2025 to Dec 31, 2026
    • Study completion date: May 31, 2025 to Aug 31, 2027
    • Eligibility criteria expanded, about 17 words
    • Site contact updated
    v7
  4. Primary and study completion dates: Mar 2025 to May 31, 2025v6
  5. Eligibility criteria expanded, about 8 wordsv5
Show 3 earlier versionsHide 3 earlier versions
  1. Phase: Phase 3 to Not applicablev4
  2. Phase: Not applicable to Phase 3v3
  3. Start date changed from estimate of May 2021 to Jul 1, 2021v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Approximately 40 million people in the US are served by private, and frequently untreated, wells. Our best estimate is that 1.3 million cases of gastrointestinal illnesses (GI) per year are attributed to consuming water from untreated private wells in the US, but in reality, there are no robust epidemiological data that can be used to estimate cases of GI attributable to these sources. We propose the first randomized controlled trial (RCT) to estimate the burden of GI associated with private well water. We will test if household treatment of private well water by ultraviolet light (UV) vs. sham (inactive UV device) decreases the incidence of GI in children under 5. We will also examine the presence of viral, bacterial, and protozoan pathogens in stool and well water from participants. These data will fill a knowledge gap on sporadic GI associated with federally-unregulated private water supplies in the US.
Trial Details
NCT Number NCT04826991
Lead Sponsor Temple University
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Conditions
(from sponsor)		 Diarrhea, Gastrointestinal Infection, Respiratory Viral Infection, Waterborne Diseases
Related terms Diarrhea, Waterborne Diseases
Enrollment 908 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov